Effect of donepezil on EEG spectral analysis in Alzheimer's disease

Acta Neurologica Belgica

Volumn 103, Issue 3, 2003, Pages 164-169

  Balkan, Sevin ^a   Yaraş, Nazmi ^a   Mihȩ, Ebru ^a   Dora, Babür ^a   Aǧar, Aysel ^a   Yargiçoǧlu, Piraye ^a  

^a Akdemiz University Sch of Medicine   (Turkey)

Author keywords

Alzheimer's disease; Donepezil; EEG spectral analysis

Indexed keywords

DONEPEZIL;

ADULT; AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; PARIETAL LOBE; PATIENT MONITORING; TEMPORAL LOBE; THETA RHYTHM;

EID: 0242523774     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 217 : 408-414.
2. Basar E. A study of the time and frequency characteristics of the potentials evoked in the acoustical cortex. Kybernetik, 1972, 10 : 61-64.
3. Basar E. EEG-Brain Dynamics. Elsevier, Amsterdam, 1981.
4. Basar-Eroglu C., Basar E., Demiralp T., Schürmann M. P300 response : Possible psychophysiological correlates in delta and theta frequency channels. A review. International Journal of Psychophysiology, 1992, 13 : 161-179.
5. Claus J. J., Kwa V. I. H., Teunisse S., Walstra G. J. M., van Gool W. A., Koelman J. H., Ongerboer de Visser B. W. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease. Alzheimer Dis. Assoc. Disord., 1998a, 12 (3): 167-74.
6. Claus J. J., Ongerboer de Visser B. W., Walstra G. J. M., Hijdra A., Verbeeten B. Jr., van Gool W. A. Quantitative spectral electroencephalography in predicting survival in patients with early Alzheimer's disease. Arch. Neurol., 1998b, 55: 1105-1111.
7. Claus J. J., Ongerboer de Visser B. W., Bour L. J., Walstra G. J., Hijdra A., Verbeeten B. Jr., van Royen E. A., Kwa V. I., van Gool W. A. Determinants of quantitative spectral electroencephalography in early Alzheimer's disease : cognitive function, regional cerebral blood flow and computed tomography. Dement. Geriatr. Cogn. Disord., 2000, 11 (2) : 81-89.
8. Comi G., Leocani L. Neurophysiological imaging technigues in dementia. Ital. J. Neurol. Sci., 2000, 20 (8): S265-269.
9. Davies P., Maloney A. F. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 1976, 2 : 1403.
10. Davis K. L., Thal L. J., Gamzu E. R. et al., Davis C. S., Woolson R. F., Gracon S. I., Drachman D. A., Schneider L. S., Whitehouse P. J., Hoover T. M. et al. A double-blind, placebo controlled multicenter study of tacrine for Alzheimer' disease. N. Engl. J. Med., 1992, 327: 1253-1259.
11. D'Onofrio F., Salvia S., Petretta V., Bonavita V., Rodriguez G., Tedeschi G. Ouantified EEG in normal aging and dementias. Acta Neurol. Scand., 1996, 93 : 336-345.
12. Knapp M. J., Knopman D. S., Solomon P. R., Pendleburg W. W., Davis C. S., Gracon S. I. A 30 week randomized, controlled trial of high dose tacrine in patients with Alzheimer's disease. JAMA, 1994, 271 :985-991.
13. Kogan E. A., Korczyn A. D., Virchovsky R. G., Klimovitzky S. S., Treves T. A., Neufeld M. Y. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J. Neural. Transm., 2001, 108 (10) : 1167-1173.
14. Kwa V. I., Weinstein H. C., Posthumus Mevjes E. F., van Royen E. A., Bour L. J., Verhoeff P. N., Ongerboer de Visser B. W. Spectral analysis of the EEG and 99 m-Tc-HMPAO SPECT-scan in Alzheimer's disease. Biol. Psychiatry, 1993, 33 (2) : 100-107.
15. Lopez O. L., Becker J. T., Brenner R. P., Rosen J., Bajulaiye O. I., Reynolds C. F. 3d. Alzheimer's disease with delusions and hallucinations : Neuropsychological and electroencephalographic correlates. Neurology, 1991, 41 : 906-912.
16. Penttila M., Partanen J. V., Soininen H., Riekkinen P. J. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin. Neurophysiol., 1985, 60: 1-6.
17. Perry E. K., Blessed G., Tomlinson B. E., Perry R. H., Crow T. J., Cross A. J., Dockray G. J., Dimaline R., Arregui A. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol. Aging, 1981, 2: 251-256.
18. Petit D., Lorrain D., Gauthier S., Montplaisir J. Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer's disease. Neurobiol. Aging, 1993, 14 (2) : 141-5.
19. Prichep L. S., John E. R., Ferris S. H., Reisberg B., Almas M., Alper K., Cancro R. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol. Aging, 1994, 15: 85-90.
20. Riekkinen P., Sirviomi J., Riekkinen P. Jr., Soininen H., Partanen J. The cholinergic system and EEG slow waves. Electroencephalogr. Clin. Neurophysiol., 1991, 78: 89-96.
21. Riekkinen P., Sirviomi J., Riekkinen P. Jr. Relationship between the cortical choline acetyltransferase content and EEG delta power. J. Neurosci. Res., 1990, 8: 12-20.
22. Rodriguez G., Copello F., Vitali P., Perego G., Nobili F. EEG spectral profile to stage Alzheimer's disease. Clin. Neurophysiol., 1999, 110 (10) : 1831-7.
23. Rogers S. L., Friedhoff L. T. E2020 improves cognition and quality of life in patients with mild- to moderate Alzheimer's disease : Results of a phase II trial. Neurology, 1994, 44 (suppl 2) : A165.
24. Rogers S. L., Friedhoff L. T. The efficacy and safety of donepezil in patients with Alzheimer's disease : results of a US multicentre, randomized, double-blind, placebo-controlled trial. The donepezil study group. Dementia, 1996, 7 : 293-303.
25. Schreiter-Gasser U., Gasser T., Ziegler P. Quantitative EEG analysis in early onset Alzheimer's disease : correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr. Clin. Neurophysiol., 1994, 90 : 267-272.
26. Shigeta M., Persson A., Viitanen M., Winblad B., Nordberg A. EEG regional changes during long-term treatment with tetrahydroaminocridine (THA) in Alzheimer's disease. Acta Neurol. Scand. Suppl., 1993, 149: 58-61.
27. Soininen H., Partanen J., Laulumaa V., Paakkonen A., Helkala E. L., Riekkinen P. J. Serial EEG in Alzheimer's disease : 3 year follow-up and clinical outcome. Electroencephalogr. Clin. Neurophysiol., 1991, 79 : 342-348.
28. Soininen H., Partanen V. J., Laulumaa V., Helkala E. L., Laakso M., Riekkinen P. J. Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol., 1989, 72 (4) : 290-7.
29. Weiner M. F., Martin-Cook K., Foster B. M., Saine K., Fontaine C. S., Svetlik D. A. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J. Clin. Psychiatry, 2000, 61 (7): 487-492.
30. Zubenko G. S., Moosy J., Martinez A. J., Rao G. R., Kopp U., Hanin I. A brain regional analysis of morphometric and cholinergic abnormalities in Alzheimer's disease. Arch. Neurol., 1989, 46: 634-638.